A Irmandade da Santa Casa de Misericórdia de São Paulo é uma instituição privada e laica considerada como um dos maiores hospitais filantrópicos da América Latina. A assistência é financiada pelo Sistema Único de Saúde conjuntamente com as serventias extrajudiciais e o Governo do Estado de São Paulo.

During the past decade, Irmandade da Santa Casa de Misericórdia de São Paulo conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 10 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Irmandade da Santa Casa de Misericórdia de São Paulo" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Faculdade de Ciências Médicas da Santa Casa de São Paulo" with 4 trials sponsored, "Irmandade da Santa Casa de Misericordia de Sao Paulo" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "Cristália Produtos Químicos Farmacêuticos Ltda." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irmandade da Santa Casa de Misericórdia de São Paulo" #1 collaborator was "Ministry of Health, Brazil" with 3 trials as a collaborator, "Irmandade da Santa Casa de Misericordia de Sao Paulo" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ache Laboratorios Farmaceuticos S.A." with 1 trials as a collaborator and "Ankara University" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Irmandade da Santa Casa de Misericórdia de São Paulo" are "Multiple Myeloma" (4 trials), "Cardiovascular Diseases" (2 trials), "Cognitive Impairment" (2 trials), "Influenza A" (2 trials) and "Abdominal Aortic Aneurysm" (1 trials). Many other conditions were trialed in "Irmandade da Santa Casa de Misericórdia de São Paulo" in a lesser frequency.

Most popular intervention types in "Irmandade da Santa Casa de Misericórdia de São Paulo" are "Drug" (26 trials), "Other" (9 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dexamethasone" (4 trials), "Intensive Control of Systolic Blood Pressure (SBP)" (2 trials), "Niraparib" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Irmandade da Santa Casa de Misericórdia de São Paulo" are 36 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Irmandade da Santa Casa de Misericórdia de São Paulo". 2 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Irmandade da Santa Casa de Misericórdia de São Paulo, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Irmandade da Santa Casa de Misericórdia de São Paulo, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".

Irmandade da Santa Casa de Misericórdia de São Paulo has several departments that took part in Clinical trials: "Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia" - 2 trials